20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T3338 | Ceralasertib | AZD6738 | ATM/ATR |
Ceralasertib (AZD6738) is an orally active, and selective ATR kinase inhibitor with IC50 of 1 nM. | |||
T5175 | Azd1390 | ATM/ATR | |
AZD1390 is an exceptionally potent inhibitor of ATM in cells (IC50: 0.78 nM) with >10,000-fold selectivity over closely related members of the PIKK family of enzymes. | |||
T3032 | VE-821 | ATR Inhibitor IV | ATM/ATR |
VE-821 (ATR Inhibitor IV) is a selective ATP competitive inhibitor of ATR( Ki/IC50: 13/26 nM in cell-free assays). | |||
T4443 | AZ32 | ATM/ATR | |
AZ32 is an orally bioavailable and blood-brain barrier-penetrating ATM inhibitor with an IC50 of <6.2 nM for ATM enzyme, and an IC50 of 0.31 μM for ATM in cell. | |||
T1958 | AZ20 | ATM/ATR , mTOR | |
AZ20 is an effective and specific inhibitor of ATR kinase (IC50: 5 nM, in a cell-free assay), 8-fold selectivity over mTOR. | |||
T6612 | NU6027 | ATM/ATR , DNA-PK , CDK | |
NU6027 is a potent ATR/CDK inhibitor, inhibits CDK1/2, ATR and DNA-PK with Ki of 2.5 μM/1.3 μM, 0.4 μM and 2.2 μM, enter cells more readily than the 6-aminopurine-based inhibitors. | |||
T6770 | AZD0156 | Apoptosis , ATM/ATR | |
AZD0156 , an effective and specific inhibitors of ATM kinase, is potential antineoplastic activities and chemo-/radio-sensitizing. | |||
T1821 | CGK733 | CGK 733 | ATM/ATR |
CGK733 (CGK 733) is a potent and selective inhibitor of ATM/ATR. | |||
T6261 | CP-466722 | CP 466722,CP466722 | ATM/ATR |
CP-466722, an effective and reversible ATM inhibitor, does not inhibit ATR and PI3K or PIKK family members in cells. | |||
T7318 | Elimusertib | BAY-1895344 | ATM/ATR |
Elimusertib (BAY-1895344) is a potent, highly selective and orally available ATR inhibitor with an IC50 of 7 nM.Elimusertib shows potent anti-tumor efficacy in monotherapy and strong combination potential with the target... | |||
T2084 | ETP-46464 | ATM/ATR , DNA-PK , PI3K , mTOR | |
ETP-46464 is an effective and specific ATR inhibitor (IC50: 25 nM). | |||
TN1673 | Garcinone C | ATM/ATR , CDK , STAT , AChR , Antifection | |
Garcinone C is a xanthone derivative extracted from Garcinia oblongifolia Champ with anti-inflammatory, astringency, and granulation-promoting activities. Garcinone C is an AChE inhibitor and has potential cytotoxic effe... | |||
T2685 | KU-55933 | ATM Kinase Inhibitor | ATM/ATR , DNA-PK , PI3K , mTOR , Autophagy |
KU-55933 (ATM Kinase Inhibitor) is a potent and specific ATM inhibitor. | |||
T7122 | AZD-7648 | DNA-PK | |
AZD-7648 is an inhibitor of DNA-dependent protein kinase (DNA-PK) with the IC50 of 0.63 nM in an enzyme assay,has anti-tumor activity. | |||
T19663 | Triheptanoin | UX 007,IND106011,UX007,UX-007,IND 106011,IND-106011 | Others |
Triheptanoin (IND 106011) is a fatty acid metabolic modulator. It potentially for the treatment of fatty acid oxidation disorders and GLUT1. | |||
T10406 | Tuvusertib | M1774,ATR inhibitor 1 | Apoptosis , ATM/ATR , Others , Chk |
Tuvusertib (M1774) is an orally available ataxia telangiectasia and Rad3-related (ATR) kinase inhibitor (Ki< 1 µΜ) with selective and potentially antitumor activity.Tuvusertib selectively inhibits ATR activity and blocks... | |||
T40077 | ATR-IN-9 | ||
ATR-IN-9 is a highly effective inhibitor of Ataxia-telangiectasia and RAD-3-related protein kinase (ATR). With an IC50 value as low as 10 nM, ATR-IN-9 demonstrates exceptional potency. | |||
T83753 | RAD17-derived Peptide TFA | ||
RAD17-derived peptide, a substrate for the ataxia-telangiectasia and RAD3-related protein/kinase (ATR), facilitates the identification of ATR inhibitors. | |||
T39523 | Antitumor agent-28 | ||
Antitumor agent-28 is a compound that specifically targets and inhibits the activity of the ataxia telangiectasia mutated (ATM) kinase. By doing so, it effectively impedes the progression of ATM-mediated diseases and dem... | |||
T78711 | A011 | ATM/ATR | |
A011, a potent and selective ataxia-telangiectasia mutated (ATM) inhibitor, exhibits an IC50 of 1.0 nM and triggers apoptosis as well as G2/M phase cell cycle arrest when combined with CPT-11, displaying notable antitumo... |